Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXF3IL
|
||||
| Drug Name |
[3-(1H-Indol-2-yl)-propyl]-[2-(2-methoxy-phenoxy)-ethyl]-amine
|
||||
| Synonyms |
CHEMBL2112645
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H24N2O2
|
||||
| Canonical SMILES |
COc1ccccc1OCCNCCCc2c[nH]c3ccccc23
|
||||
| InChI |
InChI=1S/C20H24N2O2/c1-23-19-10-4-5-11-20(19)24-14-13-21-12-6-7-16-15-22-18-9-3-2-8-17(16)18/h2-5,8-11,15,21-22H,6-7,12-14H2,1H3
|
||||
| InChIKey |
STPTYZMDTOSUMZ-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.